Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Trellis Bioscience
AddedFeb 17, 2024
UpdatedJun 18, 2026
Trellis Bioscience

Trellis Bioscience

Seed

US-based Trellis Bioscience develops therapeutic antibody treatments for infectious diseases and cancer.

HQ
San Francisco, CA, US
Founded
1998
Overview
Compare
Fundraising
Employees
Website

Founded in Menlo Park, Trellis Bioscience is a biotechnology company dedicated to developing therapeutic antibody treatments for infectious diseases and cancer. The company's core mission is to harness the power of native human monoclonal antibodies to combat severe health conditions, aiming to improve patient outcomes and advance global health. Trellis Bioscience's product pipeline includes innovative treatments targeting bacteria, viruses, and oncology indications.

Notable figures affiliated with Trellis Bioscience include a distinguished management team and board of directors with extensive experience in biotechnology and pharmaceuticals. The company has received significant recognition, including FDA Fast Track and QIDP designations for its TRL1068 antibody, underscoring its commitment to addressing urgent medical needs. Trellis Bioscience's pioneering work has made a substantial impact in the fields of infectious diseases and oncology, positioning it as a leader in therapeutic antibody development.

Trellis Bioscience - Similar Companies

Treeline Biosciences logo

Treeline Biosciences

TRex Bio logo

TRex Bio

trex.bio

Trelys logo

Trelys

Dren Bio logo

Dren Bio

drenbio.com

Abterra Biosciences logo

Abterra Biosciences

abterrabio.com

Zebra Biologics logo

Zebra Biologics

AltruBio logo

AltruBio

TrueBinding logo

TrueBinding

truebinding.com

3T Biosciences logo

3T Biosciences

3tbiosciences.com

Idbiologics logo

Idbiologics

idbiologics.com

Upstream Bio logo

Upstream Bio

upstreambio.com

Celldex Therapeutics logo

Celldex Therapeutics

Trancura Biosciences logo

Trancura Biosciences

Tallac Therapeutics logo

Tallac Therapeutics

MacroGenics logo

MacroGenics

macrogenics.com

Trellis Bioscience - Quick Facts

Who are Trellis Bioscience's competitors?

Companies similar to Trellis Bioscience include Treeline Biosciences, TRex Bio, Trelys and Dren Bio.

When was Trellis Bioscience founded?

Trellis Bioscience was founded in 1998.

Where is Trellis Bioscience's headquarters located?

Trellis Bioscience's headquarters is located in San Francisco, CA, US.

When was Trellis Bioscience's last funding round?

Trellis Bioscience's most recent funding round was for $3.2M (USD) in October 2019.

How much has Trellis Bioscience raised to-date?

As of Oct 1, 2019, Trellis Bioscience has raised a total of $28.6M (USD).

How many employees does Trellis Bioscience have?

Trellis Bioscience has 75 employees as of Feb 5, 2024.

Trellis Bioscience - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Antibody Treatments
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering
Show 15 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 8733Noncommercial Research Organizations
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified